An Epilepsy-Associated SV2A Mutation Disrupts Synaptotagmin-1 Expression and Activity-Dependent Trafficking

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Synaptic vesicle protein 2A (SV2A) is linked to epilepsy, but the precise mechanisms causing presynaptic dysfunction and seizures remain unclear.
• Understanding SV2A's role is crucial for developing epilepsy treatments.

Purpose of the Study:

• To investigate how the first identified human SV2A mutation (R383Q) associated with epilepsy impacts SV2A function and presynaptic activity.
• To determine if SV2A's interaction with synaptotagmin-1 (Syt1) is critical for its role in epilepsy.

Main Methods:

• Utilized a molecular replacement strategy to express exogenous SV2A in mouse neuronal cultures lacking endogenous SV2A.
• Analyzed the localization, trafficking, and binding of wild-type and R383Q mutant SV2A.
• Assessed the impact of SV2A mutations on Syt1 expression and activity-dependent trafficking.

Main Results:

• The R383Q mutation caused SV2A mislocalization to the plasma membrane without affecting activity-dependent trafficking.
• SV2A R383Q exhibited reduced mobility and impaired binding to Syt1.
• The R383Q mutant failed to rescue Syt1 expression and trafficking deficits in SV2A-depleted neurons.

Conclusions:

• The SV2A R383Q mutation disrupts Syt1 regulation at the presynapse.
• Impaired control of Syt1 expression and trafficking by dysfunctional SV2A may be a critical step in the transition to epilepsy.